SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
Abstract Sodium-glucose co-transporter 2 inhibitors (SGLT2is), primarily used for managing type 2 diabetes mellitus, have recently gained attention for their potential cardiovascular benefits. This review explores the emerging evidence surrounding the association between SGLT2is and arrhythmias. Ini...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-01-01
|
| Series: | International Journal of Arrhythmia |
| Online Access: | https://doi.org/10.1186/s42444-024-00109-6 |